IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CATALANO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.261
AS - Asia 6.213
EU - Europa 6.121
SA - Sud America 524
AF - Africa 94
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 10
Totale 19.248
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.078
SG - Singapore 2.070
CN - Cina 1.957
GB - Regno Unito 1.841
IT - Italia 981
SE - Svezia 746
RU - Federazione Russa 686
VN - Vietnam 556
HK - Hong Kong 501
DE - Germania 366
BR - Brasile 365
FR - Francia 352
NL - Olanda 281
IN - India 275
IE - Irlanda 231
TR - Turchia 225
UA - Ucraina 170
BD - Bangladesh 157
KR - Corea 138
FI - Finlandia 116
CA - Canada 112
EU - Europa 88
ID - Indonesia 77
JP - Giappone 62
DK - Danimarca 58
CO - Colombia 55
AR - Argentina 46
BE - Belgio 44
PL - Polonia 38
IQ - Iraq 34
AT - Austria 32
ES - Italia 29
MX - Messico 29
CH - Svizzera 25
GR - Grecia 25
CI - Costa d'Avorio 20
ZA - Sudafrica 18
AU - Australia 17
MY - Malesia 15
RO - Romania 15
SA - Arabia Saudita 15
UZ - Uzbekistan 14
MA - Marocco 13
VE - Venezuela 13
CL - Cile 12
HU - Ungheria 12
JM - Giamaica 12
TW - Taiwan 12
CZ - Repubblica Ceca 11
EC - Ecuador 11
IR - Iran 11
PH - Filippine 10
PK - Pakistan 10
PT - Portogallo 10
BO - Bolivia 9
LU - Lussemburgo 9
PY - Paraguay 9
NZ - Nuova Zelanda 8
TH - Thailandia 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
HR - Croazia 7
SC - Seychelles 7
SK - Slovacchia (Repubblica Slovacca) 7
AZ - Azerbaigian 6
JO - Giordania 6
KE - Kenya 6
KZ - Kazakistan 6
LB - Libano 6
NO - Norvegia 6
MK - Macedonia 5
PA - Panama 5
SI - Slovenia 5
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
MM - Myanmar 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BB - Barbados 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GT - Guatemala 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
PE - Perù 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
A1 - Anonimo 2
BF - Burkina Faso 2
CR - Costa Rica 2
HN - Honduras 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
Totale 19.303
Salva come PNG Salva come JPEG
Città #
Southend 1.637
Singapore 1.170
Chandler 636
Ashburn 528
Hong Kong 434
San Jose 405
Beijing 402
Santa Clara 359
Milan 352
Princeton 330
Seattle 235
Council Bluffs 231
Dublin 230
Ann Arbor 214
Wilmington 203
Los Angeles 179
Fairfield 170
Jacksonville 158
Dallas 138
Nanjing 129
Lauterbourg 128
Des Moines 112
Ho Chi Minh City 111
Bengaluru 105
Woodbridge 103
Buffalo 96
Guangzhou 88
New York 85
Redmond 84
Hanoi 83
Dong Ket 82
Moscow 80
Somerville 76
Houston 75
Serra 74
Boardman 70
Cambridge 62
Berlin 60
Shenyang 57
Andover 55
Mountain View 55
Dearborn 54
Istanbul 54
Redwood City 54
Toronto 54
Cangzhou 51
Jinan 51
Bogotá 48
Shanghai 48
Nanchang 47
Central District 46
Sakarya 45
Jakarta 42
São Paulo 42
Brussels 41
Helsinki 41
Changsha 39
Hebei 39
The Dalles 39
Columbus 37
Hangzhou 35
Tianjin 34
Tokyo 34
Fuzhou 32
Hefei 27
Phoenix 26
Shenzhen 26
Frankfurt am Main 25
Warsaw 23
Zhengzhou 23
San Diego 22
Jiaxing 21
Munich 21
Rome 21
Abidjan 20
Enschede 20
Grafing 20
Medford 20
Chicago 19
Seoul 19
Wuhan 19
Kunming 16
Quanzhou 16
Boston 15
Dhaka 14
Hanover 14
Naples 14
Taizhou 14
Athens 13
Manchester 13
Verona 13
Amsterdam 12
Bologna 12
Falls Church 12
London 12
Nuremberg 12
Orem 12
Pisa 12
Florence 11
Haiphong 11
Totale 11.508
Salva come PNG Salva come JPEG
Nome #
Arterial stiffness and 5-year mortality in patients with peripheral arterial disease 413
Both HIV-infection and long-term antiretroviral therapy are associated with increased common carotid intima-media thickness in HIV-infected adolescents and young adults 280
Radial artery compliance in patients with peripheral vascular disease 273
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo : Evidence derived from the study of peripheral arterial disease 273
La mutazione C677T del gene methylene tetrahydrofolate reductase nell'arteriopatia periferica 267
Finally, the big picture of morbidity and mortality in peripheral arterial disease? 267
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee 261
VAS european book on angiology/vascular medicine 257
Arterial stiffness and subendocardial viability ratio in patients with peripheral arterial disease 243
The PLAT Study : a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients 240
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group 239
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study 239
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group 235
Effects of treatment with verapamil SR and captopril on the lipid profile of hypertensive patients 217
Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness 213
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group 213
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients 210
The PLAT Study : hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group Progetto Lombardo Atero-Trombosi (PLAT) Study Group 209
Alterazioni strutturali dell'arteria radiale in pazienti con arteriopatia aterosclerotica periferica 207
Thrombin generation profile in patients with steady state peripheral arterial disease 204
The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease 202
Elastic properties and structure of the radial artery in patients with type 2 diabetes 202
Impact of mild hypertriglyceridemia on fibrinolysis, Lp(a) and platelet activation index in mildly hypercolesterolemic patients 200
Aortic augmentation index in patients with peripheral arterial disease 200
Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudication 200
Basal nitric oxide production is not reduced in patients with noninsulin-dependent diabetes mellitus 199
Proposed training requirements for Medical Angiology fellows. European Working Group on Medical Angiology 199
Lp(a) in hypertensive patients 193
The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease 190
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine 187
La flunarizina nel trattamento delle arteriopatie degli arti inferiori 186
Arterial damage, triglycerides, apolipoprotein and Lp(a) values in PVD patients 184
Serum lipids and apolipoproteins in patients with essential hypertension 180
Increased superoxide anion production in humans: a possible mechanism for the pathogenesis of hypertension 179
Arterial stiffness: a review in Type 2 diabetes 179
Carotid artery plaque composition : Relationship to clinical presentation and ultrasound B-mode imaging 178
Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia [The Oral Iloprost in severe Leg Ischaemia Study Group] 177
Energetics of walking in patients with peripheral arterial disease : a proposed functional evaluation protocol 176
Relationship of arterial stiffness and ankle-brachial index 175
Increased aortic stiffness and related factors in patients with peripheral arterial disease 174
Cadralazine in combination with three different doses of atenololol in essential hypertension 173
The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke 172
Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press 164
Arterial stiffness and its relationship to mortality in patients with peripheral artery disease 163
A multicenter study of doxazosin in the treatment of patients with mild or moderate essential hypertension and concomitant intermittent claudication 160
Long-term HIV Infection is Associated with Increased Carotid Intima Media Thickness in HIV-infected Adolescents 159
Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease : randomized, double-blind trial 151
Influence of storage time on whole blood platelet aggregation 151
Skin blood flow during vasoconstrictive and vasodilative stimuli in essential hypertension patients: a laser Doppler flowmetry study 150
Isradipine in the treatment of peripheral occlusive vascular disease of the lower limbs: a pilot study 148
Simvastatin and the apolipoprotein profile in primary hypercholesterolemia 146
The case for the speciality of medical angiology 145
Endoteline e patologie umane 144
Epidemiology of critical limb ischaemia : north Italian data 143
Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification 143
Cadralazine (ISF 2469): dose-related antihypertensive activity after single oral administration to patients 139
Epidemiology of peripheral artery disease in Europe : VAS educational paper 139
Controlled clinical trial of cadralazine as a second-step drug in the treatment of hypertension 136
Platelet activation markers in patients with peripheral arterial disease - a prospective comparison of different platelet function tests 135
PAD awareness : role of educational project 135
Evaluation of a conservative treatment with iIoprost in severe peripheral occlusive arterial disease (POAD) : GISAP study 135
Fibrinolytic variables in atherosclerotic patients-comparison between patients with and without peripheral arterial-disease (PAD) 133
The case for the specialty of medical angiology 132
"No more amputations" : a complex scientific problem and a challenge for effective preventive strategy implementation on vascular field 132
Fibrinolytic variables in prediction of atherothrombotic sequelae in patients with preexisting vascular ischaemic disease : the plat study 132
29th Annual Scientific Sessions, SVM Fellows Course, and International Collaboration with VAS 132
Il complesso antitrombofilico di parete arteriosa nella terapia delle arteriopatie obliteranti degli arti inferiori 130
Un estratto di corteccia surrenale nella terapia di supporto dei pazienti neoplastici 129
A stable strategy for European education in angiology/vascular medicine 126
Arterial Stiffness 126
Reprinted Article "carotid artery plaque composition - Relationship to clinical presentation and ultrasound b-mode imaging" 126
Aging and Vascular Disease: A Multidisciplinary Overview 125
Medical angiologists. Europe already has them 125
Creazione e sviluppo delle UO di Angiologia 123
Nitric oxide is involved in the insulin release in rat by L-aeginine 123
Treatment of claudication with dipyridamole and aspirin 122
Beta-TG and plasma catecholamines levels after sympathetic stimuli in hypertensives and patients with peripheral vascular disease 121
Arterial stiffness in young patients with peripheral arterial disease 120
Introduction by the VAS Board 119
A stable strategy for European education in angiology/vascular medicine 116
Introduction by the Editors 116
UEMS training requirements for angiology e vascular medicine : European standards of postgraduate medical specialist training (ETR document) 115
The Italian node of the research infrastructure BBMRI 115
Validity of Out-Patient Screening in Arteriosclerosis to Identify Multiple Lesions 113
Captopril for the Treatment of Patients with Hypertension and Peripheral Vascular Disease 112
Platelet activation indices and apolipoproteins in hypertensive patients 111
Apolipoproteins and LP(A) correlations in patients at risk 111
Peripheral Arterial Disease : stages I and II 110
Requirements for angiology/vascular medicine 109
Variazioni del quadro lipoproteico in pazienti affetti da cardiopatia coronarica 109
Plasma beta-thromboglobulin levels and claudication degrees in patients with peripheral vascular disease 109
BTG and PF4 values before and after effort in patients treated with ketanserin 109
Effetto del verapamil SR e del captopril sul metabolismo apolipoproteico in pazienti ipertesi 107
Effectof sympathetic stimuli on platelet activation in patient with essential hypertension or peripheral vascular disease 107
Terapia con tiadenolo nei pazienti dislipidemici 106
Test da sforzo su ergometro nelle arteriopatie obliteranti periferiche 105
Study on vascular reactivity in Raynaud's phenomenon: laser Doppler and iontophoresis evaluation 105
Prioritisation of treatments for lower extremity peripheral artery disease in low- and middle-income countries 104
Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial 103
Enhancement in walking ability and ankle blood-pressure under ticlopidine in 2nd-stage peripheral arterial-disease (PAD) patients – a 21 month double-blind study 103
Totale 16.422
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.484
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021247 0 0 0 0 0 0 0 0 0 0 0 247
2021/20221.577 131 55 75 97 83 89 131 160 132 173 82 369
2022/20232.031 295 215 160 244 232 408 54 110 173 33 79 28
2023/2024890 40 93 54 43 190 48 31 60 15 35 105 176
2024/20253.271 138 321 43 330 489 106 62 289 145 300 273 775
2025/20265.607 538 263 520 400 729 487 641 287 783 472 381 106
Totale 20.351